SLC5A5 and thyroid gland carcinoma: Although 131I is an effective therapeutic modality for thyroid cancers that express sodium iodide symporter (NIS), a substantial percentage of metastatic thyroid carcinomas do not express adequate levels of the protein and are categorized as radioiodine refractory thyroid cancers.